Gland Pharma Ltd EPS

Gland Pharma Ltd EPS

Image

Gland Pharma Ltd

NSE: GLAND

EPS

₹ 69.44

Last updated on: Sep 29, 2026

Key Highlights

  • The Earning per Share of Gland Pharma Ltd is ₹ 69.44 as of 29 Sep 26 The earning per share of Gland Pharma Ltd changed from ₹ 8.73 to ₹ 19.23 over 9 quarters. This represents a CAGR of 42.05% .

Historical Earning per Share of Gland Pharma Ltd

No data available

* All values are in ₹

Company Fundamentals for Gland Pharma Ltd

Market Cap

49,315 Cr

EPS

69.4

P/E Ratio (TTM)

43.0

P/B Ratio (TTM)

4.8

Day’s High

3004.45

Day’s Low

2924.6

DTE

0.0

ROE

9.9

52 Week High

3041.95

52 Week Low

1575.0

ROCE

14.0

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Sep 20262988.6
28 Sep 20262895.5
25 Sep 20262915.4
24 Sep 20262897.85
23 Sep 20262908
22 Sep 20262916.9
21 Sep 20262941.65
18 Sep 20262961.9
17 Sep 20262910.65
16 Sep 20262829.2

SWOT Analysis Of Gland Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Gland Pharma Ltd

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

₹ 49,315

Asset Value

Value addition

5.5 X

₹ 7,621

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Gland Pharma Ltd49315
Sun Pharmaceutical Industries Ltd446276
Divis Laboratories Ltd251531
Torrent Pharmaceuticals Ltd186957
Zydus Lifesciences Ltd119222
Cipla Ltd111729

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in ₹ crore

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Gland Pharma Ltd News Hub

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s

Read more

07 Aug 24

Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai

Read more

06 Aug 24

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c

Read more

05 Aug 24

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1

Read more

09 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Oct 2022

PPT

July 2022

TranscriptPPT

FAQs for EPS of Gland Pharma Ltd

What is the EPS of Gland Pharma Ltd stock?

The Earnings Per Share (EPS) of Gland Pharma Ltd is 69.44. An EPS is the amount of net income attributed to each share of a common stock.

How is Gland Pharma Ltd EPS calculated?

The EPS of Gland Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Gland Pharma Ltd report its EPS?

Gland Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Gland Pharma Ltd EPS?

Factors that influence the EPS of Gland Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Gland Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Gland Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions